SecSonar.com

Milestone Pharmaceuticals Inc. (MIST)

Milestone Pharmaceuticals Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Milestone Pharmaceuticals Inc. (MIST) is a Biotechnology company based in CA with a market capitalization of $124.1M. Free cash flow was negative at -$49.3M. This page tracks MIST's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CA · 33 employees · IPO May 9, 2019

Valuation

Valuation & price

$1.50 · as of May 17, 2026 · -49.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.97

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.69$1.86$1.04Jul 25Dec 25Jul 26Jul 7, 25$2.17Jul 9, 25$2.40Jul 11, 25$1.56Jul 15, 25$1.48Jul 17, 25$1.65Jul 21, 25$1.49Jul 23, 25$1.60Jul 25, 25$1.58Jul 29, 25$1.46Jul 31, 25$1.45Aug 4, 25$1.49Aug 6, 25$1.53Aug 11, 25$1.55Aug 13, 25$1.74Aug 15, 25$1.70Aug 19, 25$1.67Aug 21, 25$1.71Aug 25, 25$1.69Aug 27, 25$1.77Aug 29, 25$1.84Sep 3, 25$1.78Sep 5, 25$1.80Sep 9, 25$1.72Sep 11, 25$1.91Sep 16, 25$1.95Sep 18, 25$1.95Sep 22, 25$2.01Sep 24, 25$1.94Sep 26, 25$2.00Sep 30, 25$2.00Oct 2, 25$2.18Oct 6, 25$2.12Oct 8, 25$2.00Oct 10, 25$1.99Oct 14, 25$2.05Oct 16, 25$1.97Oct 21, 25$2.03Oct 23, 25$1.89Oct 27, 25$1.91Oct 29, 25$1.84Oct 31, 25$1.92Nov 4, 25$1.84Nov 6, 25$1.72Nov 10, 25$1.85Nov 12, 25$1.93Nov 14, 25$2.00Nov 18, 25$2.41Nov 20, 25$2.31Nov 25, 25$2.47Nov 28, 25$2.69Dec 2, 25$2.65Dec 4, 25$2.64Dec 8, 25$2.66Dec 10, 25$2.67Dec 12, 25$2.41Dec 16, 25$2.20Dec 18, 25$2.08Dec 22, 25$2.07Dec 24, 25$2.07Dec 29, 25$2.04Jan 2, 26$2.05Jan 6, 26$2.05Jan 8, 26$2.19Jan 12, 26$1.96Jan 14, 26$2.03Jan 16, 26$2.05Jan 21, 26$2.01Jan 23, 26$1.98Jan 27, 26$2.01Jan 29, 26$1.89Feb 2, 26$1.96Feb 4, 26$1.87Feb 9, 26$1.82Feb 11, 26$1.82Feb 13, 26$1.70Feb 18, 26$1.67Feb 20, 26$1.70Feb 24, 26$1.74Feb 26, 26$1.72Mar 2, 26$1.73Mar 4, 26$1.65Mar 6, 26$1.58Mar 10, 26$1.78Mar 12, 26$1.75Mar 17, 26$1.78Mar 19, 26$1.70Mar 23, 26$1.26Mar 25, 26$1.25Mar 27, 26$1.04Mar 31, 26$1.19Apr 2, 26$1.38Apr 7, 26$1.61Apr 9, 26$2.01Apr 13, 26$2.00Apr 15, 26$2.20Apr 17, 26$2.10Apr 22, 26$2.01Apr 24, 26$1.89Apr 28, 26$1.85Apr 30, 26$1.80May 4, 26$1.90May 6, 26$1.97May 8, 26$1.92May 12, 26$1.90May 14, 26$1.63May 18, 26$1.46May 20, 26$1.50May 22, 26$1.41May 28, 26$1.44Jun 1, 26$1.36Jun 3, 26$1.28Jun 5, 26$1.23Jun 9, 26$1.21Jun 11, 26$1.27Jun 15, 26$1.31Jun 17, 26$1.31Jun 22, 26$1.31Jun 24, 26$1.27Jun 26, 26$1.24Jul 2, 26$1.32
$1.0152-week range$2.95
Loading valuation history…

Fundamentals

Key fundamentals

$124.1M

Market cap

—

Revenue growth (YoY)

92.6%

Gross margin

-$49.3M

Free cash flow (USD)

-$47.6M

Net debt

Net cash position

34.8%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$15.0MFY 2022$5.0MFY 2023$1.0MFY 2024$0.00FY 2025$1.5M
$0$1.5M

Free cash flow by year

2017 → 2025

FY 2017$-8.1MFY 2018$-21.1MFY 2019$-51.6MFY 2020$-50.7MFY 2021$-33.2MFY 2022$-52.7MFY 2023$-46.5MFY 2024$-28.9MFY 2025$-49.3M
-$8.1M-$49.3M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 202592.6%
100.0%92.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEquity Incentive Plan AmendmentJun 15, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • FinancingSecurities RegistrationMay 13, 2026Filing
  • Insider sellInsider Sell $82K · 10b5-1 PlanOliveto Joseph · Director, President and CEO · $82.5KApr 20, 2026Filing

Questions

Frequently asked questions

What is Milestone Pharmaceuticals Inc.'s market cap?

Milestone Pharmaceuticals Inc. (MIST) has a market capitalization of $124.1M.

What is MIST's P/E ratio?

A meaningful P/E ratio is not available for MIST — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is MIST's price-to-book (P/B) ratio?

MIST trades at 2.97 times book value per share.

Are insiders buying MIST stock?

SEC Form 4 filings show no open-market insider buys at Milestone Pharmaceuticals Inc. in the last 90 days (1 sell).

Same arena

Related companies in Biotechnology

CRDF

Cardiff Oncology, Inc.

$124.8M

IKT

Inhibikase Therapeutics, Inc.

$125.3M

ALPS

Alps Group Inc

$121.8M

KRRO

Korro Bio, Inc.

$129.6M

BDTX

Black Diamond Therapeutics, Inc.

$130.1M

GNLX

Genelux Corporation

$114.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.